Stonehage Fleming Financial Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.15M Sell
14,304
-505
-3% -$41.6K 0.04% 72
2025
Q4
$1.26M Sell
14,809
-650
-4% -$53.3K 0.04% 57
2025
Q3
$1.2M Sell
15,459
-1,621
-9% -$127K 0.03% 57
2025
Q2
$1.34M Buy
+17,080
New +$1.27M 0.04% 52
2025
Q1
Sell
-2,202,161
Closed -$163M 211
2024
Q4
$163M Sell
2,202,161
-77,640
-3% -$5.43M 4.56% 11
2024
Q3
$150M Sell
2,279,801
-23,139
-1% -$1.68M 3.97% 12
2024
Q2
$213M Buy
+2,302,940
New +$204M 5.68% 5
2024
Q1
Sell
-2,298,940
Closed -$175M 205
2023
Q4
$175M Buy
2,298,940
+1,917,239
+502% +$133M 5.13% 8
2023
Q3
$26.5M Sell
381,701
-829,811
-68% -$66.7M 2.35% 16
2023
Q2
$114M Buy
+1,211,512
New +$105M 4.17% 9
2022
Q3
Sell
-653,743
Closed -$62.2M 215
2022
Q2
$62.2M Buy
653,743
+140,066
+27% +$14.5M 2.49% 18
2022
Q1
$60.4M Buy
+513,677
New +$57.6M 1.87% 23
2021
Q4
Sell
-1,072,893
Closed -$121M 229
2021
Q3
$121M Sell
1,072,893
-1,106
-0.1% -$126K 3.58% 12
2021
Q2
$111M Buy
1,073,999
+8,248
+0.8% +$777K 3.25% 12
2021
Q1
$89.1M Buy
1,065,751
+123,915
+13% +$10.5M 2.97% 12
2020
Q4
$85.8M Buy
+941,836
New +$78.1M 2.89% 14
2020
Q3
Sell
-630,254
Closed -$43.5M 170
2020
Q2
$43.5M Buy
630,254
+410,099
+186% +$29.1M 2.95% 15
2020
Q1
$13.9M Buy
+220,155
New +$15.9M 0.69% 22
2019
Q4
Sell
-22,947
Closed -$1.68M 193
2019
Q3
$1.68M Hold
22,947
0.08% 43
2019
Q2
$1.42M Buy
+22,947
New +$1.39M 0.07% 51
2017
Q4
Sell
-24,552
Closed -$894K 236
2017
Q3
$894K Hold
24,552
0.04% 102
2017
Q2
$968K Hold
24,552
0.06% 88
2017
Q1
$770K Buy
+24,552
New +$769K 0.05% 130
2016
Q4
Sell
-22,704
Closed -$912K 307
2016
Q3
$912K Hold
22,704
0.05% 117
2016
Q2
$755K Sell
22,704
-1,164
-5% -$39.8K 0.05% 122
2016
Q1
$702K Buy
+23,868
New +$659K 0.05% 119

Other funds holding EW